Study of Talazoparib With Enzalutamide in Men With DDR Gene Mutated mCSPC (NCT04821622)

🧪 Interventions in This Study

• talazoparib plus enzalutamide (DRUG)
• Placebo plus enzalutamide (DRUG)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (313 Sites)

Showing the first 25 of 313 sites.

• University of Alabama at Birmingham — Birmingham, Alabama
• University of Alabama at Birmingham — Birmingham, Alabama
• Arizona Institute of Urology, PLLC — Tucson, Arizona
• Beverly Hills Cancer Center — Beverly Hills, California
• Adventist Health Glendale — Glendale, California
• VA Long Beach Healthcare System — Long Beach, California
• Yale-New Haven Hospital — New Haven, Connecticut
• MedStar Georgetown University Hospital — Washington D.C., District of Columbia
• Washington Cancer Institute at MedStar Washington Hospital Center — Washington D.C., District of Columbia
• AdventHealth Medical Group Hematology and Oncology — Orlando, Florida
• Investigational Drug Services, Advent Health Orlando — Orlando, Florida
• Northwest Georgia Oncology Centers, a Service of WellStar Cobb Hospital — Austell, Georgia
• Wellstar Cobb Hospital — Austell, Georgia
• Northwest Georgia Oncology Centers, a Service of Tanner Medical Center Villa Rica — Carrollton, Georgia
• West Georgia Infusion Center, a Service of Tanner Medical Center Villa Rica — Carrollton, Georgia
• Northwest Georgia Oncology Centers, a Service of WellStar Cobb Hospital — Cartersville, Georgia
• Northwest Georgia Oncology Centers, a Service of WellStar Cobb Hospital — Douglasville, Georgia
• Northwest Georgia Oncology Centers, a Service of Wellstar Cobb Hospital — Marietta, Georgia
• Comprehensive Urologic Care, SC — Lake Barrington, Illinois
• Mid-Illinois Hematology & Oncology Associates, Ltd — Normal, Illinois
• Henry Ford Health System — Detroit, Michigan
• Henry Ford Medical Center - New Center One — Detroit, Michigan
• Revive Research Institute, Inc. — Farmington Hills, Michigan
• David C. Pratt Cancer Center — St Louis, Missouri
• New Jersey Cancer Care, P.A. — Belleville, New Jersey

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Prostate Cancer

• A Study of Apalutamide (JNJ-56021927, ARN-509) Plus Androgen Deprivation Therapy (ADT) Versus ADT in Participants With mHSPC — Homewood, Alabama
• A Study in Which Non-metastatic Castration-resistant Prostate Cancer (nmCRPC) Patients for Whom a Decision to Treat With Darolutamide Has Been Made Before Enrollment Are Observed and Certain Outcomes Are Described — Homewood, Alabama
• Stereotactic Ablative Radiation Therapy for Prostate Cancer — Charleston, South Carolina
• A Study of Stereotactic Body Radiation Therapy (SBRT) Without Androgen Deprivation Therapy (ADT) in People With Unfavorable Intermediate-Risk Prostate Cancer — Basking Ridge, New Jersey
• A Study of Abiraterone Acetate Plus Prednisone With or Without Abemaciclib (LY2835219) in Participants With Prostate Cancer — Phoenix, Arizona
• Neoadjuvant Enoblituzumab (MGA271) in Men With Localized Intermediate and High-Risk Prostate Cancer — Baltimore, Maryland

Explore by condition: All Prostate Cancer clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Review the official NIH record below to find the coordinating site.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.